Infections
Baloxavir marboxil
Antiviral Agent (Endonuclease Inhibitor)
Other names: Xofluza
Wait
48 hours
after the first dose
The FAA's MedGuide lists baloxavir marboxil (Xofluza) as allowed, for influenza or viral infection, with a wait of 48 hours after the first dose and none after later doses or after the final dose, used as prescribed.
Track your medicationsMore detail: baloxavir marboxilThe rest of Crosscheck's reading, in plain wordsOpen
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
- 48 hours after the first dose: ground observation
Show the FAA's words: baloxavir marboxilThe official FAA wording: three passages, each with its document and dateOpen
Generic: baloxavir marboxil
Brand Name: Xofluza
Drug Class: Antiviral Agent (Endonuclease Inhibitor)
Underlying Condition: Influenza; Viral infection
Use: ALLOW
INITIAL Wait Time (after first dose): 48 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.